Medicare Enrolled

Dr. Neil Nagovski, MD

Hematology & Oncology · Miami, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
8900 N KENDALL DR, Miami, FL 33176
7865962000
In practice since 2006 (20 years)
NPI: 1588635668 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nagovski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nagovski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nagovski

Dr. Neil Nagovski is a hematology & oncology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nagovski performed 1,348 Medicare services across 649 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nagovski received a total of $528,115 from 63 pharmaceutical and/or device companies across 802 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nagovski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 36% volume in FL $528,115 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,348
Medicare services
Top 36% in FL for hematology & oncology
649
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~67 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 741 $75 $329
Office visit, established patient (20-29 min) 202 $50 $223
Office visit, established patient, complex (40-54 min) 114 $103 $483
New patient office visit (45-59 min) 76 $102 $453
Hospital follow-up visit, high complexity 65 $97 $384
Initial hospital admission, high complexity 48 $136 $682
Biopsy and aspiration of bone marrow sample for diagnosis 31 $61 $265
Hospital follow-up visit, moderate complexity 25 $65 $254
Initial hospital admission, moderate complexity 16 $107 $462
New patient office visit (30-44 min) 15 $60 $281
New patient office visit, complex (60-74 min) 15 $139 $625
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$528,115
Total received (2018-2024)
Avg $75,445/year across 7 years
Top 2% in FL for hematology & oncology
63
Companies
802
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$473,885 (89.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$47,365 (9.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,865 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$125,399
2023
$92,338
2022
$120,332
2021
$60,474
2020
$54,711
2019
$73,797
2018
$1,064

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$171,441
E.R. Squibb & Sons, L.L.C.
$72,896
GlaxoSmithKline, LLC.
$68,050
Celgene Corporation
$67,182
Incyte Corporation
$49,129
Novartis Pharmaceuticals Corporation
$36,736
AstraZeneca Pharmaceuticals LP
$29,420
Kite Pharma, Inc.
$11,747
RECORDATI_RARE_DISEASES_INC.
$3,591
TAIHO ONCOLOGY, INC.
$3,286
Janssen Biotech, Inc.
$1,952
Adaptive Biotechnologies Corporation
$1,879
CTI BioPharma Corp.
$1,738
NOVARTIS PHARMACEUTICALS CORPORATION
$1,575
MorphoSys, US Inc.
$1,455
PFIZER INC.
$1,397
BeiGene, Ltd.
$450
Genentech USA, Inc.
$446
Merck Sharp & Dohme Corporation
$377
Shire North American Group Inc
$301
Astellas Pharma US Inc
$265
Amgen Inc.
$252
Daiichi Sankyo Inc.
$200
Lilly USA, LLC
$178
Teva Pharmaceuticals USA, Inc.
$172
SANOFI-AVENTIS U.S. LLC
$163
Advanced Accelerator Applications
$160
ABBVIE INC.
$159
Seagen Inc.
$157
PUMA BIOTECHNOLOGY, INC.
$120
Bayer HealthCare Pharmaceuticals Inc.
$116
Takeda Pharmaceuticals U.S.A., Inc.
$104
Janssen Pharmaceuticals, Inc
$72
Gilead Sciences, Inc.
$69
Exelixis Inc.
$61
Kyowa Kirin, Inc.
$60
Seattle Genetics, Inc.
$58
EMD Serono, Inc.
$58
Merck Sharp & Dohme LLC
$50
Pharmacyclics LLC, An AbbVie Company
$45
Eisai Inc.
$40
Ipsen Biopharmaceuticals, Inc
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
Partner Therapeutics, Inc.
$36
Foundation Medicine, Inc.
$34
TerSera Therapeutics LLC
$29
ADC Therapeutics America, Inc.
$25
Octapharma USA, Inc.
$25
Mylan Institutional Inc.
$24
EUSA Pharma (US) LLC
$24
Fortovia Therapeutics, Inc.
$23
ImmunoGen, Inc.
$23
Clovis Oncology, Inc.
$22
Sobi, Inc
$20
Verastem, Inc.
$20
TOLMAR Pharmaceuticals, Inc.
$19
Mirati Therapeutics, Inc.
$18
Agios Pharmaceuticals, Inc.
$17
Dova Pharmaceuticals
$17
Genmab U.S., Inc.
$16
Tempus AI, Inc
$15
Aurobindo Pharma USA, Inc.
$15
Karyopharm Therapeutics Inc.
$12
Top 3 companies account for 59.2% of total payments
Associated products mentioned in payments ›
6 · ADCETRIS · ADVATE · ALIMTA · Alecensa · Aliqopa · Avastin · BENDEKA · BLENREP · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CALQUENCE · CERDELGA · CEREZYME · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FOUNDATIONONE · Fabhalta · Folotyn · Fulphila · GAZYVA · GILOTRIF · GLEEVEC · Gazyva · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · Inrebic · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LEUKINE · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONJUVI · MYLOTARG · NINLARO · Neulasta · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · PADCEV · PANHEMATIN · PIQRAY · PLUVICTO · POTELIGEO · PROCRIT · PROMACTA · Phesgo · Pomalyst · Prolia · REBLOZYL · RECOTHROM · RYBREVANT · RYDAPT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SYLVANT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · Tecentriq · VENCLEXTA · VPRIV · Vectibix · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Yescarta · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for hematology & oncology in FL.

Equivalent to $39,178 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Miami?
Compare hematology & oncology specialists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
133
Per 100K population
5.0
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nagovski is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nagovski experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nagovski performed 741 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nagovski receive payments from pharmaceutical companies?
Yes. Dr. Nagovski received a total of $528,115 from 63 companies across 802 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nagovski's costs compare to other hematology & oncology specialists in Miami?
Dr. Nagovski's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nagovski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →